172 related articles for article (PubMed ID: 15675409)
1. [Duloxetine receives positive recommendation by the Scientific Committee of EMEA for treatment of depression].
Krankenpfl J; 2004; 42(7-10):247. PubMed ID: 15675409
[No Abstract] [Full Text] [Related]
2. [Duloxetine reduces pain and depression].
Krankenpfl J; 2004; 42(7-10):246-7. PubMed ID: 15675408
[No Abstract] [Full Text] [Related]
3. Duloxetine--three birds with one stone?
Michel MC
Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
[No Abstract] [Full Text] [Related]
4. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
5. [Change in the point of view].
Krankenpfl J; 2005; 43(1-3):23-4. PubMed ID: 15912818
[No Abstract] [Full Text] [Related]
6. Duloxetine: an innovative approach for treating stress urinary incontinence.
Van Kerrebroeck P
BJU Int; 2004 Jul; 94 Suppl 1():31-7. PubMed ID: 15139861
[No Abstract] [Full Text] [Related]
7. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.
Thor KB; Kirby M; Viktrup L
Int J Clin Pract; 2007 Aug; 61(8):1349-55. PubMed ID: 17608681
[TBL] [Abstract][Full Text] [Related]
8. [Duloxetine. A new preparation for patients with urinary incontinence].
Walter S
Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
[TBL] [Abstract][Full Text] [Related]
9. [Duloxetin effective in depression and pain: high remission rates obtained].
MMW Fortschr Med; 2006 Jun; 148(23):63. PubMed ID: 16826744
[No Abstract] [Full Text] [Related]
10. [Physical complaints can overlap mental symptoms. Diffuse pain? Think about depression!].
MMW Fortschr Med; 2006 Jun; 148(23):62. PubMed ID: 16826743
[No Abstract] [Full Text] [Related]
11. [Physical recovery is part of remission].
Krankenpfl J; 2004; 42(3-4):110. PubMed ID: 15311907
[No Abstract] [Full Text] [Related]
12. [FDA approval for the antidepressive drug Cymbalta].
Krankenpfl J; 2004; 42(5-6):154. PubMed ID: 15527218
[No Abstract] [Full Text] [Related]
13. Innovations in pharmacotherapy for stress urinary incontinence.
Cannon TW; Yoshimura N; Chancellor MB
Int Urogynecol J Pelvic Floor Dysfunct; 2003 Dec; 14(6):367-72. PubMed ID: 14676995
[TBL] [Abstract][Full Text] [Related]
14. Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder.
Liu X; Gelwicks S; Faries DE; Able SL
Int Clin Psychopharmacol; 2010 Nov; 25(6):315-22. PubMed ID: 20706125
[TBL] [Abstract][Full Text] [Related]
15. Role of serotonin and noradrenaline in stress urinary incontinence.
Michel MC; Peters SL
BJU Int; 2004 Jul; 94 Suppl 1():23-30. PubMed ID: 15139860
[No Abstract] [Full Text] [Related]
16. [Duloxetine (Yentreve) in the general practice test: recommendation by the experts. Effective and tolerable therapy of symptoms in female stress incontinence].
Krankenpfl J; 2005; 43(7-10):189-90. PubMed ID: 16515261
[No Abstract] [Full Text] [Related]
17. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
Westanmo AD; Gayken J; Haight R
Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
[TBL] [Abstract][Full Text] [Related]
18. [A challenge].
Krankenpfl J; 2005; 43(4-6):93. PubMed ID: 16171044
[No Abstract] [Full Text] [Related]
19. Intensive monitoring of duloxetine: results of a web-based intensive monitoring study.
Härmark L; van Puijenbroek E; van Grootheest K
Eur J Clin Pharmacol; 2013 Feb; 69(2):209-15. PubMed ID: 22688722
[TBL] [Abstract][Full Text] [Related]
20. The treatment of urinary incontinence with Duloxetine.
Basu M; Duckett J
J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
